About Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical is a publicly listed company based in Toyama (Japan) founded in 1965. Generic and biosimilar pharmaceuticals are developed, manufactured, and distributed. Nichi-Iko Pharmaceutical has completed 1 acquisition, including Sagent Pharma. Its chief executive, as recorded, is Yuichi Tamura. Its website nichiiko.co.jp draws about 162 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Nichi-Iko Pharmaceutical was established in 1965 in Toyama, Japan, within the generic and biosimilar pharmaceutical sector. A variety of medications is developed, produced, and distributed through the complete lifecycle, including research, manufacturing, and supply chains. Affordable options are made available to patients globally. Quality standards are enforced across all stages to uphold safety and effectiveness. Support materials are furnished for patients and healthcare providers.
- Headquarters Toyama, Japan
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website nichiiko.co.jp
- Investments & Acquisitions
People of Nichi-Iko Pharmaceutical
1 people are tracked at Nichi-Iko Pharmaceutical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Yuichi Tamura | CEO | Leadership |
Complete people profiles for Nichi-Iko Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sagent Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Injectable generic pharmaceuticals are supplied across multiple therapeutic categories. | sagentpharma.com | Schaumburg, United States | 2006 | Jul 2016 | •••• |
Complete acquisition details for Nichi-Iko Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Nichi-Iko Pharmaceutical
3 dated milestones of Nichi-Iko Pharmaceutical across 51 years, from founding to its latest funding, stage changes and deals.
- Founded Nichi-Iko Pharmaceutical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Sagent Pharma.
Web traffic of Nichi-Iko Pharmaceutical
The website of Nichi-Iko Pharmaceutical (nichiiko.co.jp) receives about 162.1K visits a month and ranks #260,290 among all websites worldwide, #8,811 in Biotechnology and Pharmaceuticals.
- Monthly visits162.1K
▲ 13% vs previous month
- Unique visitors106.3K
per month
- Global rank#260,290
among all websites
- Category rank#8,811
Health · Biotechnology and Pharmaceuticals
- Bounce rate44%
- Pages per visit2.6
- Average visit1 min 22 sec
- DevicesDesktop 42% · Mobile 58%
Websites whose visitors overlap most with Nichi-Iko Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
drugshortage.jp | drugshortage.jp | 100% | #139,609 | – | |
| towayakuhin.co.jp | 91% | 314.3K | #192,945 | View details | |
| sawai.co.jp | 86% | 1M | #64,184 | View details | |
viatris-e-channel.com | viatris-e-channel.com | 83% | #639,169 | – | |
| chugai-pharm.co.jp | 81% | 180.8K | #220,597 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Nichi-Iko Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nichi-Iko Pharmaceutical
Complete news archive for Nichi-Iko Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nichi-Iko Pharmaceutical
Nichi-Iko Pharmaceutical was founded in 1965.
Nichi-Iko Pharmaceutical is headquartered in Toyama, Japan. It is registered at Toyama, Toyama, Japan.
Yuichi Tamura is the CEO of Nichi-Iko Pharmaceutical, as recorded in our data.
Nichi-Iko Pharmaceutical was established in 1965 in Toyama, Japan, within the generic and biosimilar pharmaceutical sector. A variety of medications is developed, produced, and distributed through the complete lifecycle, including research, manufacturing, and supply chains. Affordable options are made available to patients globally. Quality standards are enforced across all stages to uphold safety and effectiveness. Support materials are furnished for patients and healthcare providers.
Nichi-Iko Pharmaceutical has made 1 acquisition, including Sagent Pharma.
The website of Nichi-Iko Pharmaceutical receives about 162 thousand visits a month and ranks #260,290 among all websites worldwide.